Expression of endostatin and its relationship with the clinical pathophysiological characteristics in non-small cell lung cancer

Chinese Journal of Lung Cancer

Volumn 5, Issue 6, 2002, Pages 447-450

  Liu, Ying ^a   Zhou, Qinghua ^a   Zhang, Shangfu ^a   Liu, Lunxu ^a   Li, Fengyuan ^a   Xue, Yang ^a   Che, Guowei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Endostatin; Immunohistochemistry; Lung neoplasms

Indexed keywords

BIOLOGICAL MARKER; ENDOSTATIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER SIZE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG INJURY; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPH NODE; MALE; MOLECULAR BIOLOGY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SMOKING HABIT;

EID: 0036927527     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 1997,88(2): 277-285.
2. Boehm T, Folkman J, Browder T, et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature, 1997, 390(6658): 404-407.
3. Homer JJ, Greenman J, Stafford ND. Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcimona. Clin Otolaryngol, 2000, 25(6): 570-576.
4. Strik HM, Schluesener HJ, Seid K, et al. Localization of endostatin in rat and human gliomas. Cancer, 2001, 91(5): 1013-1019.
5. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med, 1995, 1(1): 27-31.
6. Wu Z, O'Reilly MS, Folkman J, et al. Suppression of tumor growth with recombinant murine angiostatin. Biochem Biophys Res Commun, 1997, 236(3): 651-654.
7. Musso O, Rehn M, Theret N, et al. Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen X VIII in human hepatocellular carcinomas. Cancer Res, 2001, 61(1): 45-49.